A Exploratory Study of Vγ2Vδ2 T Lymphocyte-based Immunotherapy for MDR-TB
Clinical trial NCT05493267 · RECRUITING
Trial details
- NCT number
- NCT05493267
- Sponsor
- Shanghai Pulmonary Hospital, Shanghai, China
- Status
- RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2022-08-03
- Primary completion
- 2025-08-03
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.